Lv11
20 积分 2023-04-20 加入
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
2小时前
求助中
Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
26天前
已完结
Lymphoblastic lymphoma
1个月前
已完结
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer
1个月前
已完结
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
1个月前
已完结
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
2个月前
已完结
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
2个月前
已完结
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
2个月前
已完结
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma
2个月前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
